“We are pleased to announce that we have received FDA approval to begin human clinical trials,” the company said in a statement. It is emphasized that this is an important first step, “which will one day allow our technology to help many people,” quotes RIA Novosti.
It is also reported that information on the recruitment of participants for clinical trials will be announced in the near future.
In late 2022, Musk reported that Neuralink was seeking government approval to test the neural brain-computer interface in humans. As the businessman pointed out, the “revolutionary brain implant” can not only solve problems such as insomnia and paralysis, but also give the user “superhuman vision”.